From New Mechanisms to New Standards of Care
Focusing on Improving Patient Outcomes in Infectious Diseases
Latest News
News / 01 Aug 2019
Summit Therapeutics to Present at the Canaccord Genuity Growth Conference
News / 17 Jul 2019
Summit Highlighted Potential of SMT-571 to Combat the Rising Global Health Threat of Gonorrhoea at STI & HIV World Congress
News / 09 Jul 2019
Summit’s DDS-04 Enterobacteriaceae Programme Demonstrates In Vivo Efficacy in Sepsis and Pneumonia
We are building a very different antibiotics company that focuses on bringing innovation to antibiotic development. Our new mechanism antibiotics are designed to become the new standards of care for the benefit of patients and create value for payors and healthcare providers.
Chief Executive Officer
2019 AGM
The AGM will be held on 19 June 2019 and more information is available from the dedicated page in the investors section
Latest Event
Slingshot Insights Management Call
Our Discuva Platform
Our technology platform is at the heart of our research to develop new mechanism antibiotics